Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19203945 | AI-Assisted Raman Spectroscopy System for Biomarker Analysis of Aqueous Humor | May 2025 | November 2025 | Allow | 6 | 2 | 1 | Yes | No |
| 19176058 | TEMPERATURE SELF-COMPENSATION INTERVENTIONAL OPTICAL FIBER PRESSURE GUIDEWIRE AND WIRELESS FFR MONITOR | April 2025 | December 2025 | Allow | 8 | 2 | 0 | Yes | No |
| 18850666 | AUTOMATIC DETECTION SYSTEM AND DEVICE FOR CAPTURING ICTAL SEMIOLOGY OF EPILEPTIC PATIENT | September 2024 | February 2026 | Abandon | 16 | 2 | 0 | No | No |
| 18679796 | DEVICE FOR PROCESSING AND VISUALIZING DATA OF AN ELECTRIC IMPEDANCE TOMOGRAPHY APPARATUS FOR DETERMINING AND VISUALIZING REGIONAL VENTILATION DELAYS IN THE LUNGS | May 2024 | October 2025 | Allow | 16 | 2 | 0 | Yes | Yes |
| 17917082 | A METHOD AND A SYSTEM FOR DETECTING AND OVERCOMING A DEVIATING GAIT | October 2022 | January 2026 | Abandon | 40 | 1 | 0 | No | No |
| 17952260 | METHOD AND SYSTEM FOR SUPPORTING MOTHERS OF NEWBORN INFANTS DURING BREASTFEEDING | September 2022 | October 2025 | Abandon | 36 | 1 | 0 | No | No |
| 17873051 | TOOTH ANALYSIS SERVER, TOOTH ANALYSIS TERMINAL, AND TOOTH ANALYSIS PROGRAM | July 2022 | January 2026 | Abandon | 42 | 1 | 0 | No | No |
| 17832472 | DEVICE AND METHOD FOR LOCATING TARGET CEREBRAL POINTS IN MAGNETIC RESONANCE IMAGES | June 2022 | December 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17636478 | BIOLOGICAL SAMPLE COLLECTION DEVICE AND METHOD OF USING SAME | February 2022 | November 2025 | Abandon | 45 | 0 | 1 | No | No |
| 17625907 | SYSTEMS AND METHODS FOR DETECTING COGNITIVE DECLINE WITH MOBILE DEVICES | January 2022 | July 2025 | Abandon | 43 | 0 | 1 | No | No |
| 17625318 | METHOD FOR STABILIZING CONTINUOUS BLOOD GLUCOSE MONITORING SYSTEM | January 2022 | February 2026 | Abandon | 49 | 2 | 0 | No | No |
| 17646078 | METHOD FOR CHARACTERIZING BLOOD PRESSURE | December 2021 | October 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17620772 | BIOMEDICAL ELECTRODE, BIOMEDICAL SENSOR, AND BIOMEDICAL SIGNAL MEASUREMENT SYSTEM | December 2021 | December 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17533596 | BLOOD PRESSURE MEASUREMENT SYSTEMS AND METHODS | November 2021 | November 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17595234 | SYSTEMS AND METHODS FOR ACCESSING A RENAL CAPSULE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | November 2021 | October 2025 | Allow | 47 | 3 | 0 | Yes | No |
| 17595070 | FINGER CLIP TYPE OXIMETRY DEVICE ADAPTIVE TO THICK AND THIN FINGERS | November 2021 | April 2025 | Allow | 41 | 2 | 0 | No | No |
| 17606485 | HEART RATE SENSOR AND ELECTRONIC DEVICE FOR COLLECTING HEART RATE | October 2021 | October 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17505527 | WOUND MEASUREMENT | October 2021 | February 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17450697 | METHOD AND SYSTEM FOR PERSONALIZED EYE BLINK DETECTION | October 2021 | August 2025 | Abandon | 46 | 4 | 0 | Yes | No |
| 17600388 | BIOLOGICAL SAMPLE CAPTURING DEVICE | September 2021 | October 2025 | Abandon | 49 | 2 | 0 | No | No |
| 17441858 | METHOD AND DEVICE FOR MEASURING OR DETERMINING AT LEAST ONE BIOMECHANICAL PARAMETER OF SOFT BIOLOGICAL TISSUES | September 2021 | August 2025 | Allow | 46 | 2 | 1 | No | No |
| 17441836 | MICRONEEDLE PATCH, REALTIME BLOOD SUGAR MONITORING DEVICE, AND REALTIME BLOOD SUGAR MONITORING METHOD USING SAME | September 2021 | February 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17441364 | BLOOD VOLUME PULSE SIGNAL DETECTION APPARATUS, BLOOD VOLUME PULSE SIGNAL DETECTION APPARATUS METHOD, AND COMPUTER-READABLE STORAGE MEDIUM | September 2021 | October 2025 | Abandon | 48 | 2 | 0 | Yes | No |
| 17441055 | A SWEAT SENSING SYSTEM | September 2021 | April 2025 | Allow | 43 | 2 | 0 | No | Yes |
| 17409177 | BIOMARKER MONITORING SENSOR AND METHODS OF USE | August 2021 | April 2025 | Allow | 43 | 2 | 1 | Yes | No |
| 17426332 | MEDICAL DEVICE WITH MISALIGNED CANNULA | July 2021 | August 2025 | Abandon | 49 | 2 | 0 | No | No |
| 17443405 | FEMALE URINE COLLECTION AND DRAINAGE DEVICE AND METHODS OF USE THEREOF | July 2021 | November 2024 | Allow | 40 | 1 | 0 | Yes | No |
| 17385046 | FOREHEAD TEMPERATURE MEASUREMENT SYSTEM WITH HIGH ACCURACY | July 2021 | December 2025 | Allow | 53 | 5 | 0 | Yes | Yes |
| 17423420 | EXTENSION CATHETER AND METHOD FOR PRODUCING SAME | July 2021 | May 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17421260 | DEVICE FOR VENOUS-PRESSURE SENSING | July 2021 | March 2025 | Allow | 44 | 2 | 0 | Yes | Yes |
| 17369099 | DERMAL IMAGE CAPTURE | July 2021 | August 2025 | Allow | 49 | 3 | 0 | No | No |
| 17420636 | SPORTS PAD WITH FORCE SENSORS | July 2021 | May 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17360512 | CHILDBIRTH AND LABOR MONITORING METHOD AND SYSTEM | June 2021 | April 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17348714 | HYBRID BODY TEMPERATURE MEASUREMENT SYSTEM AND METHOD THEREOF | June 2021 | September 2024 | Allow | 39 | 3 | 0 | No | No |
| 17347582 | ORTHOSTATIC REPORTING ASSEMBLY, ORTHOSTATIC REPORTING SYSTEM, AND RELATED METHOD OF USE | June 2021 | September 2025 | Abandon | 51 | 2 | 1 | Yes | No |
| 17345500 | COLLECTION OF CELLS FROM BIOLOGICAL FLUID | June 2021 | February 2025 | Abandon | 44 | 2 | 0 | Yes | No |
| 17413098 | MONITOR SYSTEM OF MULTIPLE PARKINSON'S DISEASE SYMPTOMS AND THEIR INTENSITY | June 2021 | July 2025 | Allow | 49 | 3 | 0 | Yes | No |
| 17335417 | PULSE DETECTION APPARATUS AND PULSE DETECTION METHOD | June 2021 | November 2024 | Abandon | 42 | 2 | 0 | No | No |
| 17294617 | SELF-MONITORING AND CARE ASSISTANT FOR ACHIEVING GLYCEMIC GOALS | May 2021 | December 2024 | Abandon | 43 | 1 | 0 | No | No |
| 17307562 | TRANSPARENT FACE MASK WITH OPTIONAL TEMPERATURE MONITORING DEVICE AND OPTIONAL DETACHABLE EYE PROTECTION | May 2021 | October 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17306708 | SYSTEM AND DEVICE FOR WATERJET NECROSECTOMY | May 2021 | October 2024 | Abandon | 41 | 1 | 0 | No | No |
| 17284053 | Digital Endoscope | April 2021 | July 2025 | Allow | 51 | 3 | 0 | Yes | No |
| 17282226 | DEVICE FOR COLLECTING POLYPS | April 2021 | January 2025 | Abandon | 45 | 2 | 0 | No | No |
| 17214157 | SYSTEMS AND METHODS FOR DEPOSITING MATERIAL IN A PATIENT | March 2021 | April 2025 | Abandon | 48 | 2 | 0 | No | No |
| 17199558 | STICKING-TYPE CORE BODY THERMOMETER | March 2021 | July 2024 | Allow | 40 | 1 | 0 | No | No |
| 17275701 | BREATH SAMPLER | March 2021 | March 2025 | Allow | 48 | 3 | 0 | No | No |
| 17189537 | PATIENT BODY MONITORING USING RADAR | March 2021 | April 2024 | Allow | 37 | 2 | 0 | No | No |
| 17271810 | BIRTH DELIVERY MAGNETIC TRACKING SYSTEM | February 2021 | June 2025 | Abandon | 52 | 3 | 0 | No | No |
| 17271282 | BLOOD PRESSURE MEASUREMENT DEVICE, VEHICLE DEVICE, AND BLOOD PRESSURE MEASUREMENT PROGRAM | February 2021 | June 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17270677 | A Sleep Monitoring System For Monitoring And Measuring Sleeping Activity | February 2021 | August 2025 | Abandon | 54 | 3 | 0 | No | No |
| 17269067 | SYSTEM AND METHOD FOR PROVIDING AN INDICATION OF A PERSON'S GUM HEALTH | February 2021 | April 2025 | Allow | 50 | 3 | 1 | Yes | No |
| 17165285 | SENSOR UNIT AND BED APPARATUS | February 2021 | July 2024 | Abandon | 42 | 1 | 0 | No | No |
| 17156277 | SYSTEMS AND METHODS TO PROVIDE A PHYSICIAN INTERFACE THAT ENABLES A PHYSICIAN TO ASSESS ASTHMA OF A SUBJECT AND PROVIDE THERAPEUTIC FEEDBACK | January 2021 | November 2024 | Abandon | 46 | 2 | 0 | No | No |
| 17154870 | SYSTEMS AND METHODS FOR ELECTROMYOMETRIAL IMAGING | January 2021 | May 2024 | Allow | 40 | 2 | 1 | No | No |
| 17146966 | BIOMETRIC DATA MEASUREMENT SYSTEM AND BIOMETRIC DATA MEASUREMENT METHOD | January 2021 | August 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 17147185 | Impairment Detection Method and Devices | January 2021 | May 2024 | Abandon | 40 | 1 | 0 | No | No |
| 17251618 | APPARATUS FOR SENSING | December 2020 | January 2026 | Abandon | 60 | 4 | 0 | No | No |
| 17114200 | OCULAR MICRO TREMOR (OMT) SENSOR, SYSTEM AND METHOD | December 2020 | February 2025 | Allow | 51 | 3 | 0 | Yes | No |
| 16972137 | SAMPLE REMOVAL ASSEMBLY FOR GYNECOLOGICAL EXAMINATIONS | December 2020 | May 2024 | Abandon | 41 | 1 | 0 | No | No |
| 16950258 | APPARATUS AND METHOD FOR ESTIMATING BIO-INFORMATION | November 2020 | May 2025 | Abandon | 54 | 3 | 0 | Yes | No |
| 17054804 | BODY SENSOR | November 2020 | January 2025 | Abandon | 51 | 2 | 0 | No | No |
| 17048454 | COMPONENT CONCENTRATION MEASUREMENT DEVICE AND COMPONENT CONCENTRATION MEASUREMENT METHOD | October 2020 | April 2025 | Abandon | 54 | 3 | 0 | No | No |
| 17064033 | DEVICE FOR PROCESSING AND VISUALIZING DATA OF AN ELECTRIC IMPEDANCE TOMOGRAPHY APPARATUS FOR DETERMINING AND VISUALIZING REGIONAL VENTILATION DELAYS IN THE LUNGS | October 2020 | December 2024 | Abandon | 50 | 2 | 1 | Yes | No |
| 17044643 | PRESSURE BASED BLOOD VESSEL ASSESSMENT SYSTEMS AND METHODS | October 2020 | August 2024 | Abandon | 46 | 1 | 0 | No | No |
| 17037207 | CANARY ON A CHIP: EMBEDDED SENSORS WITH BIO-CHEMICAL INTERFACES | September 2020 | May 2025 | Allow | 55 | 3 | 0 | No | No |
| 17033335 | OCULAR ABERROMETER SYSTEMS AND METHODS | September 2020 | March 2025 | Allow | 54 | 4 | 0 | Yes | Yes |
| 17040298 | HEART FAILURE DEGREE-OF-EXACERBATION DETERMINATION SYSTEM AND HEART FAILURE DEGREE-OF-EXACERBATION DETERMINATION METHOD | September 2020 | April 2025 | Abandon | 55 | 4 | 0 | Yes | No |
| 17019156 | FEATURE-BASED JOINT RANGE OF MOTION CAPTURING SYSTEM AND RELATED METHODS | September 2020 | August 2024 | Abandon | 47 | 2 | 0 | Yes | No |
| 17003202 | Vascular Access Device Adapter | August 2020 | October 2025 | Allow | 60 | 5 | 0 | Yes | No |
| 17001902 | ON-CHIP INTEGRATED MULTI-WAVELENGTHS BIOLOGICAL SENSING DEVICE | August 2020 | June 2024 | Abandon | 45 | 2 | 0 | No | No |
| 16970657 | OBTAINING IMAGES FOR USE IN DETERMINING ONE OR MORE PROPERTIES OF SKIN OF A SUBJECT | August 2020 | February 2025 | Allow | 54 | 4 | 0 | Yes | Yes |
| 16970424 | SENSOR ARRANGEMENT FOR MOUNTING ON A GUIDEWIRE OR CATHETER | August 2020 | July 2024 | Allow | 47 | 2 | 0 | Yes | No |
| 16970244 | FLEXIBLE CIRCUIT FOR DETECTING LIQUID PRESENCE | August 2020 | February 2025 | Abandon | 54 | 3 | 0 | No | No |
| 16989363 | CATHETER SYSTEM TO FACILITATE BLOOD COLLECTION AND RELATED METHODS | August 2020 | March 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 16930125 | On-Bed Differential Piezoelectric Sensor | July 2020 | October 2024 | Abandon | 51 | 3 | 0 | Yes | No |
| 16959708 | DETACHABLE VOLUME MEASURING APPARATUS, TISSUE EXPANSION APPARATUS COMPRISING SAME AND BREAST VOLUME MEASURING METHOD USING SAME | July 2020 | March 2024 | Abandon | 45 | 0 | 1 | No | No |
| 16809253 | NEEDLE STABILIZATION SYSTEM AND METHODS OF USE | March 2020 | November 2024 | Abandon | 56 | 1 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner HOFFPAUIR, ANDREW ELI.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 80.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner HOFFPAUIR, ANDREW ELI works in Art Unit 3791 and has examined 66 patent applications in our dataset. With an allowance rate of 37.9%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 47 months.
Examiner HOFFPAUIR, ANDREW ELI's allowance rate of 37.9% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by HOFFPAUIR, ANDREW ELI receive 2.23 office actions before reaching final disposition. This places the examiner in the 62% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by HOFFPAUIR, ANDREW ELI is 47 months. This places the examiner in the 10% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +38.7% benefit to allowance rate for applications examined by HOFFPAUIR, ANDREW ELI. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 39% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 34.6% of cases where such amendments are filed. This entry rate is in the 52% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 66.7% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 58% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences show above-average effectiveness with this examiner. If you have strong arguments, a PAC request may result in favorable reconsideration.
This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 99% percentile among all examiners. Of these withdrawals, 40.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 66.7% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 48% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 50% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.